Major objections in EU medicines authorisation applications: an analysis of dossier submissions by small- and medium-sized enterprises.

Legros E, Enes L, Ziogas C

Open source

DOI
10.1016/j.drudis.2026.104721
Published
2026 Jul
Container
Drug discovery today
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.drudis.2026.104721,
  title = {Major objections in EU medicines authorisation applications: an analysis of dossier submissions by small- and medium-sized enterprises.},
  author = {Legros E and Enes L and Ziogas C},
  year = {2026},
  journal = {Drug discovery today},
  doi = {10.1016/j.drudis.2026.104721},
  url = {https://doi.org/10.1016/j.drudis.2026.104721}
}

RIS

TY  - JOUR
TI  - Major objections in EU medicines authorisation applications: an analysis of dossier submissions by small- and medium-sized enterprises.
AU  - Legros E
AU  - Enes L
AU  - Ziogas C
PY  - 2026
JO  - Drug discovery today
DO  - 10.1016/j.drudis.2026.104721
UR  - https://doi.org/10.1016/j.drudis.2026.104721
ER  - 

APA

E, L., L, E., & C, Z. (2026). Major objections in EU medicines authorisation applications: an analysis of dossier submissions by small- and medium-sized enterprises.. Drug discovery today. https://doi.org/10.1016/j.drudis.2026.104721

Source records